Cheatsheets on US pharma and insurance reform

Notes compiled from the NPLB fellowship

I was part of the Autumn 2024 cohort for the No Patient Left Behind Fellowship. I got a birds-eye view of the US pharma ecosystem, learning about areas like drug economics, the US health insurance system, DTC advertising, and more. I made some cheatsheets from my notes. Have a look and share it around. Let’s get more people to understand that pharma innovation can be made affordable with appropriate insurance reform.

Link to the cheatsheets.

It’s arranged into a few different sections:

• Biotech Social Contract and birds-eye view
• Pharma industry finances
• Pharma industry finances from a global perspective
• From cost-effectiveness analyses (CEAs) to generalised cost-effectiveness analyses (GCEAs)
• Things perceived as bad by the public
• An overview of the American healthcare system
• Challenges with insurance for patients
• Biologics and value-based agreements
• Summary of takeaways

I’d recommend feeding the notes into your favourite AI chatbot and using it as a revision tool with a prompt like “Ask me questions on [this section]”. You don’t even need to read the notes for this.